VYVGART HYTRULO

EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) · argenx US

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for VYVGART HYTRULO, covering 2023-06-20 to 2026-02-26. Get the full timeline:

Most recent: FDA Approved: VYVGART HYTRULO — Supplemental Application (argenx US)